Rethinking FDA's NMN Decision: A Missed Opportunity for Regulatory Clarity - Nutraceuticals World
The FDA can address longstanding uncertainty around ingredients like NAC by harmonizing statutory provisions instead of taking shortcuts.| Nutraceuticals World
